Tectonic Therapeutic, Inc. (TECX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $413.27M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tectonic Therapeutic, Inc. (TECX) Stock Forecast
Analysts expect Tectonic Therapeutic (TECX) to earn -$5.77 per share in the fiscal year ending Dec 31, 2026. Of 10 analysts, 9 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.76.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 90% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 10.0% |
| Buy | 8 | 80.0% |
| Hold | 1 | 10.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$5.77
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$4.76
- EPS consensus
- Next report
- Feb 24, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$5.77 | -$5.77 to -$5.77 | 1 |
| Dec 31, 2027 | -$4.76 | -$4.76 to -$4.76 | 1 |
Quarterly Estimates
The EPS consensus rises from -$1.42 for the quarter ending Dec 31, 2026 to -$1.30 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.42 | -$2.00 to -$0.92 | 11 |
| Mar 31, 2027 | -$1.30 | -$1.55 to -$0.86 | 5 |
Estimate Revisions
No EPS estimate for the 3 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$5.77 | -$5.77 | N/A | N/A | N/A | N/A |
| Fiscal year ending Dec 31, 2027 | -$4.76 | -$4.76 | N/A | N/A | N/A | N/A |
| Quarter ending Mar 31, 2027 | -$1.30 | -$1.34 | -$1.34 | -$1.34 | -$1.34 | N/A |
Frequently Asked Questions About TECX
What is the TECX stock forecast?
Consensus analyst estimates put Tectonic Therapeutic's EPS at -$5.77 for the fiscal year ending Dec 31, 2026. The consensus rating from 10 analysts is Buy.
How do analysts rate TECX stock?
Of 10 analysts covering Tectonic Therapeutic, 1 rates it Strong Buy, 8 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from TECX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.77, with estimates from -$5.77 to -$5.77 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.76, with estimates from -$4.76 to -$4.76 from 1 analyst.
How many analysts cover TECX?
10 analysts rate Tectonic Therapeutic stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
TECX pages: Overview, Earnings, Forecast, Financials, Competitors